Phospholamban Interacts with HAX-1, a Mitochondrial Protein with Anti-apoptotic Function

Journal of Molecular Biology

Volumn 367, Issue 1, 2007, Pages 65-79

  Vafiadaki, Elizabeth ^a   Sanoudou, Despina ^a   Arvanitis, Demetrios A ^a   Catino, Dawn H ^b   Kranias, Evangelia G ^a,c   Kontrogianni Konstantopoulos, Aikaterini ^b  

^a Foundation for Biomedical Research   (Greece)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

calcium homeostasis; cardiac muscle; HAX 1; phospholamban; sarcoplasmic reticulum

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; COMPLEMENTARY DNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HISTIDINE; MITOCHONDRIAL PROTEIN; PHOSPHOLAMBAN; PROTEIN HAX 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CELL PROTECTION; CELL STRAIN HEK293; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DNA LIBRARY; ENDOPLASMIC RETICULUM; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SARCOPLASMIC RETICULUM; SURFACE PLASMON RESONANCE; TRANSIENT TRANSFECTION; TWO HYBRID SYSTEM;

EID: 33847012674     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.10.057     Document Type: Article

References (61)

1. MacLennan D.H., and Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nature Rev. Mol. Cell. Biol. 4 (2003) 566-577
2. Simmerman H.K., and Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 78 (1998) 921-947
3. Inui M., Chamberlain B.K., Saito A., and Fleischer S. The nature of the modulation of Ca2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum. J. Biol. Chem. 261 (1986) 1794-1800
4. Tada M., Kirchberger M.A., and Katz A.M. Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′:5′-monophosphate-dependent protein kinase. J. Biol. Chem. 250 (1975) 2640-2647
5. Tada M., and Katz A.M. Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu. Rev. Physiol. 44 (1982) 401-423
6. Simmerman H.K., Collins J.H., Theibert J.L., Wegener A.D., and Jones L.R. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 261 (1986) 13333-13341
7. Fujii J., Ueno A., Kitano K., Tanaka S., Kadoma M., and Tada M. Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban. J. Clin. Invest. 79 (1987) 301-304
8. Pollesello P., Annila A., and Ovaska M. Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer. Biophys. J. 76 (1999) 1784-1795
9. Mascioni A., Karim C., Zamoon J., Thomas D.D., and Veglia G. Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban. J. Am. Chem. Soc. 124 (2002) 9392-9393
10. Zamoon J., Mascioni A., Thomas D.D., and Veglia G. NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys. J. 85 (2003) 2589-2598
11. Kimura Y., Kurzydlowski K., Tada M., and MacLennan D.H. Phospholamban inhibitory function is activated by depolymerization. J. Biol. Chem. 272 (1997) 15061-15064
12. 2+ pump of sarcoplasmic reticulum. Nature 342 (1989) 90-92
13. Toyofuku T., Kurzydlowski K., Tada M., and MacLennan D.H. Amino acids Lys-Asp-Asp-Lys-Pro-Val402 in the Ca(2+)-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban. J. Biol. Chem. 269 (1994) 22929-22932
14. Toyofuku T., Kurzydlowski K., Tada M., and MacLennan D.H. Amino acids Glu2 to Ile18 in the cytoplasmic domain of phospholamban are essential for functional association with the Ca(2+)-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 269 (1994) 3088-3094
15. Sharma P., Patchell V.B., Gao Y., Evans J.S., and Levine B.A. Cytoplasmic interactions between phospholamban residues 1-20 and the calcium-activated ATPase of the sarcoplasmic reticulum. Biochem. J. 335 (2001) 699-706
16. Kimura Y., Asahi M., Kurzydlowski K., Tada M., and MacLennan D.H. Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum. J. Biol. Chem. 273 (1998) 14238-14241
17. 2+ pump of cardiac sarcoplasmic reticulum. J. Biol. Chem. 280 (2005) 10530-10539
18. Kadambi V.J., Ponniah S., Harrer J.M., Hoit B.D., Dorn G.W.n., Walsh R.A., and Kranias E.G. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J. Clin. Invest. 97 (1996) 533-539
19. Dash R., Kadambi V., Schmidt A.G., Tepe N.M., Biniakiewicz D., Gerst M.J., et al. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation 103 (2001) 889-896
20. Luo W., Grupp I.L., Harrer J., Ponniah S., Grupp G., Duffy J.J., et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circulat. Res. 75 (1994) 401-409
21. Slack J.P., Grupp I.L., Dash R., Holder D., Schmidt A., Gerst M.J., et al. The enhanced contractility of the phospholamban-deficient mouse heart persists with aging. J. Mol. Cell. Cardiol. 33 (2001) 1031-1040
22. Suzuki Y., Demoliere C., Kitamura D., Takeshita H., Deuschle U., and Watanabe T. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family of tyrosine kinases. J. Immunol. 158 (1997) 2736-2744
23. Ojamaa K., Kenessey A., and Klein I. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology 141 (2000) 2139-2144
24. Mayer E.J., Huckle W., Johnson R.G.J., and McKenna E. Characterization and quantitation of phospholamban and its phosphorylation state using antibodies. Biochem. Biophys. Res. Commun. 267 (2000) 40-48
25. 2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP. J. Biol. Chem. 275 (2000) 15034-15038
26. Grzybowska E.A., Sarnowska E., Konopinski R., Wilczynska A., Sarnowski T.J., and Siedlecki J.A. Identification and expression analysis of alternative splice variants of the rat Hax-1 gene. Gene 371 (2006) 84-92
27. Cho K., Adamson L., Park J.H., Zipkin R., and Greenhalgh D. Identification of truncated form of mouse HAX-1s gene (HAX-1xs) and characterization of its expression in small intestine and thymus of mice after burn injury. Shock 18 (2002) 223-229
28. Gallagher A.R., Cedzich A., Gretz N., Somlo S., and Witzgall R. The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc. Natl Acad. Sci. USA 97 (2000) 4017-4022
29. Dufva M., Olsson M., and Rymo L. Epstein-Barr virus nuclear antigen 5 interacts with HAX-1, a possible component of the B-cell receptor signalling pathway. J. Gen. Virol. 82 (2001) 1581-1587
30. Sharp T.V., Wang H.W., Koumi A., Hollyman D., Endo Y., Ye H., et al. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J. Virol. 76 (2002) 802-816
31. Haghighi K., Kolokathis F., Pater L., Lynch R.A., Asahi M., Gramolini A.O., et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Invest. 111 (2003) 869-876
32. Chu G., Luo W., Slack J.P., Tilgmann C., Sweet W.E., Spindler M., et al. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circulat. Res. 79 (1996) 1064-1076
33. Gramolini A.O., Trivieri M.G., Oudit G.Y., Kislinger T., Li W., Patel M.M., et al. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation. Proc. Natl Acad. Sci. USA 103 (2006) 2446-2451
34. Cilenti L., Soundarapandian M.M., Kyriazis G.A., Stratico V., Singh S., Gupta S., et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J. Biol. Chem. 279 (2004) 50295-50301
35. Yedavalli V.S., Shih H.M., Chiang Y.P., Lu C.Y., Chang L.Y., Chen M.Y., et al. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1. J. Virol. 79 (2005) 13735-13746
36. Han Y., Chen Y.-S., Liu Z., Bodyak N., Rigor D., Bisping E., et al. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circulat. Res. 99 (2006) 415-423
37. Kaliman P., Catalucci D., Lam J.T., Kondo R., Gutierrez J.C., Reddy S., et al. Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum. J. Biol. Chem. 280 (2005) 8016-8021
38. 2+-dependent ATPase following phosphorylation by cAMP-dependent protein kinase. Biochem. J. 351 (2000) 195-205
39. Levine B.A., Patchell V.B., Sharma P., Gao Y., Bigelow D.J., Yao Q., et al. Sites on the cytoplasmic region of phospholamban involved in interaction with the calcium-activated ATPase of the sarcoplasmic reticulum. Eur. J. Biochem. 264 (1999) 905-913
40. Kimura Y., and Inui M. Reconstitution of the cytoplasmic interaction between phospholamban and Ca(2+)-ATPase of cardiac sarcoplasmic reticulum. Mol. Pharmacol. 61 (2002) 667-673
41. Rechsteiner M., and Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21 (1996) 267-271
42. Matsuda G., Nakajima K., Kawaguchi Y., Yamanashi Y., and Hirai K. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1. Microbiol. Immunol. 47 (2003) 91-99
43. Radhika V., Onesime D., Ha J.H., and Dhanasekaran N. Galpha13 stimulates cell migration through cortactin-interacting protein Hax-1. J. Biol. Chem. 279 (2004) 49406-49413
44. Ortiz D.F., Moseley J., Calderon G., Swift A.L., Li S., and Arias I.M. Identification of HAX-1 as a protein that binds bile salt export protein and regulates its abundance in the apical membrane of Madin-Darby canine kidney cells. J. Biol. Chem. 279 (2004) 32761-32770
45. Kasashima K., Ohta E., Kagawa Y., and Endo H. The pleiotropic human prohibitin 2: mitochondrial functions and estrogen receptor-dependent nuclear translocation. J. Biol Chem. (2006) (Epub ahead of print)
46. Kawaguchi Y., Nishimagi E., Tochimoto A., Kawamoto M., Katsumata Y., Soejima M., et al. Intracellular IL-1{alpha}-binding proteins contribute to biological functions of endogenous IL-1{alpha} in systemic sclerosis fibroblasts. Proc. Natl Acad. Sci. USA 103 (2006) 14501-14506
47. Lauriat T.L., Dracheva S., Kremerskothen J., Duning K., Haroutunian V., Buxbaum J.D., et al. Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton. Brain Res. (2006) (Epub ahead of print)
48. Mirmohammadsadegh A., Tartler U., Michel G., Baer A., Walz M., Wolf R., et al. HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis. J. Invest. Dermatol. 120 (2003) 1045-1051
49. Hippe A., Bylaite M., Chen M., von Mikecz A., Wolf R., Ruzicka T., and Walz M. Expression and tissue distribution of mouse Hax-1. Gene 371 (2006) 84-92
50. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., and Reed J.C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53 (1993) 4701-4714
51. Hacki J., Egger L., Monney L., Conus S., Rosse T., Fellay I., and Borner C. Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene 19 (2000) 2286-2295
52. Rudner J., Lepple-Wienhues A., Budach W., Berschauer J., Friedrich B., Wesselborg S., et al. Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis. J. Cell. Sci. 114 (2001) 4161-4172
53. Pinton P., Ferrari D., Magalhaes P., Schulze-Osthoff K., Di Virgilio F., Pozzan T., and Rizzuto R. Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J. Cell. Biol. 148 (2000) 857-862
54. Foyouzi-Youssefi R., Arnaudeau S., Borner C., Kelley W.L., Tschopp J., Lew D.P., et al. Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. Proc. Natl Acad. Sci. USA 97 (2000) 5723-5728
55. Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R., et al. Polycystin-2 is an intracellular calcium release channel. Nature Cell. Biol. 4 (2002) 191-197
56. Anyatonwu G.I., and Ehrlich B.E. Calcium signaling and polycystin-2. Biochem. Biophys. Res. Commun. 322 (2004) 1364-1373
57. 2+ responses. Science 280 (1998) 1763-1766
58. Rizzuto R., Pinton P., Brini M., Chiesa A., Filippin L., and Pozzan T. Mitochondria as biosensors of calcium microdomains. Cell Calcium 26 (1999) 193-199
59. 2+ signalling between sarco-endoplasmic reticulum and mitochondria. J. Physiol. 529 (2000) 69-81
60. Haghighi K., Schmidt A.G., Hoit B.D., Brittsan A.G., Yatani A., Lester J.W., et al. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J. Biol. Chem. 276 (2001) 24145-24152
61. Kontrogianni-Konstantopoulos A., Jones E.M., Van Rossum D.B., and Bloch R.J. Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Mol. Biol. Cell 14 (2003) 1138-1148